Yunnan Botanee Bio-Technology Group Co., Ltd. is a biotechnology company primarily focused on the research, development, and distribution of innovative skincare products. The company leverages advanced bio-tech techniques to create effective and safe beauty solutions that cater to a wide range of skin concerns. Its product lineup includes notable brands that are well-regarded in the beauty and personal care market, addressing the needs of both domestic and international consumers.
Operating within the dynamic and rapidly growing skincare industry, Yunnan Botanee plays a pivotal role in pioneering new approaches to skin health, emphasizing natural and sustainable ingredients. The company's commitment to quality and cutting-edge technology positions it as a leader in biotech-enhanced personal care products.
Headquartered in China, Yunnan Botanee is instrumental in merging traditional practices with modern science, significantly impacting the biotechnology and cosmetics sectors. Its products are distributed through various channels, including online platforms, allowing for extensive market reach and contributing to its prominence in the Asian cosmetics industry.
Industry
Household & Personal Products
Consumer Defensive sector · China
Stories
Structural patterns identified in Yunnan Botanee Bio-Technology Group Co., Ltd.
No stories identified yet.
Key Metrics
Market Capitalization
17.76BCNY
NormalMar 18, 2026
Trailing P/E
49.33CNY
AboveNormalMar 18, 2026
Revenue (TTM)
5.18BCNY
NormalMar 18, 2026
Forward Yield
5.73%
Annual Rate
CNY 2.40
Paid annual
Payout Ratio
70.6%
Moderate
Loading dividend history...
Track Record
Frequency
Annual
Payback Period
63.7 yr
Years to recoup investment via dividends alone
Upcoming
Ex-Dividend Date
Mar 10, 2026
Valuation9
Market Capitalization
17.76BCNY
NormalMar 18, 2026
Enterprise Value
14.89BCNY
NormalMar 18, 2026
Trailing P/E
49.33CNY
Coordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination
Profit Margin
6.95%
Normal
Mar 18, 2026
Beta
0.7120CNY
NormalMar 18, 2026
52-Week Change
-8.30CNY
ExtremeMar 18, 2026
Forward Annual Dividend Yield
5.73%
NormalMar 18, 2026
AboveNormal
Mar 18, 2026
Forward P/E
26.17CNY
NormalMar 18, 2026
PEG Ratio
26.17CNY
ExtremeMar 18, 2026
Price to Sales (TTM)
3.43CNY
NormalMar 18, 2026
Price to Book (MRQ)
2.90CNY
NormalMar 18, 2026
Enterprise to Revenue
2.87CNY
NormalMar 18, 2026
Enterprise to EBITDA
48.69CNY
AboveNormalMar 18, 2026
Profitability & Growth58
Gross Margin
75.04%
NormalMar 18, 2026
Profit Margin
6.95%
NormalMar 18, 2026
Operating Margin
-1.98%
NormalMar 18, 2026
Return on Assets (TTM)
0.0150CNY
NormalMar 18, 2026
Return on Equity (TTM)
0.0597CNY
NormalMar 18, 2026
Revenue (TTM)
5.18BCNY
NormalMar 18, 2026
Revenue per Share (TTM)
12.23CNY
NormalMar 18, 2026
Quarterly Revenue Growth
-0.0990CNY
NormalMar 18, 2026
Gross Profit (TTM)
3.78BCNY
NormalMar 18, 2026
EBITDA
829.89MCNY
ExtremeMar 18, 2026
Net Income (TTM)
360.16MCNY
NormalMar 18, 2026
Quarterly Earnings Growth (YoY)
-0.1667CNY
NormalMar 18, 2026
Operating Cash Flow (TTM)
1.13BCNY
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
589.91MCNY
NormalMar 18, 2026
Forward Annual Dividend Rate
2.40CNY
NormalMar 18, 2026
Forward Annual Dividend Yield
5.73%
NormalMar 18, 2026
Trailing Annual Dividend Rate
0.6000CNY
NormalMar 18, 2026
Trailing Annual Dividend Yield
1.43%
NormalMar 18, 2026
Payout Ratio
0.7059CNY
NormalMar 18, 2026
Minority Interest (Equity)
137.92M
NormalFY2024 · Dec 31, 2024
Revenue
5.74B
NormalFY2024 · Dec 31, 2024
Cost of Goods Sold
1.51B
NormalFY2024 · Dec 31, 2024
Gross Profit
4.23B
NormalFY2024 · Dec 31, 2024
Operating Income
576.04M
NormalFY2024 · Dec 31, 2024
Pre-tax Income
608.40M
NormalFY2024 · Dec 31, 2024
Income Tax Expense
113.61M
NormalFY2024 · Dec 31, 2024
Net Income
494.79M
NormalFY2024 · Dec 31, 2024
EBIT
625.99M
NormalFY2024 · Dec 31, 2024
ebitda-income
829.89M
NormalFY2024 · Dec 31, 2024
Research & Development
295.17M
NormalFY2024 · Dec 31, 2024
Selling, General & Administrative
2.53B
NormalFY2024 · Dec 31, 2024
Other Operating Expenses
69.71M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Income
20.53M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Expense
17.59M
NormalFY2024 · Dec 31, 2024
EPS (Basic)
1.20
NormalFY2024 · Dec 31, 2024
EPS (Diluted)
1.20
NormalFY2024 · Dec 31, 2024
Basic Shares Outstanding
419.21MShares
NormalFY2024 · Dec 31, 2024
Diluted Shares Outstanding
419.21MShares
NormalFY2024 · Dec 31, 2024
Net Income from Continuing Operations
494.79M
NormalFY2024 · Dec 31, 2024
Minority Interests (P&L)
8.26M
NormalFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00
NormalFY2024 · Dec 31, 2024
Operating Cash Flow
459.55M
NormalFY2024 · Dec 31, 2024
Free Cash Flow
316.48M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
1.74B
NormalFY2024 · Dec 31, 2024
Net Income (CF Statement)
494.79M
NormalFY2024 · Dec 31, 2024
Other Non-cash Items
63.25M
NormalFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-310.03M
NormalFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
211.54M
NormalFY2024 · Dec 31, 2024
Capital Expenditures
-374.90M
NormalFY2024 · Dec 31, 2024
Purchase of Investments
-5.05B
NormalFY2024 · Dec 31, 2024
Sale of Investments
4.34B
NormalFY2024 · Dec 31, 2024
Other Investing Activity
7.54K
NormalFY2024 · Dec 31, 2024
Net Investing Cash Flow
-1.08B
NormalFY2024 · Dec 31, 2024
Long-term Debt Issuance
837.71M
NormalFY2024 · Dec 31, 2024
Long-term Debt Payments
-310.51M
NormalFY2024 · Dec 31, 2024
Common Dividends Paid
-262.52M
NormalFY2024 · Dec 31, 2024
Other Financing Charges
-210.69M
NormalFY2024 · Dec 31, 2024
Net Financing Cash Flow
53.99M
NormalFY2024 · Dec 31, 2024
Financial Strength30
Shares Outstanding
423.60MShares
NormalMar 18, 2026
Float Shares
134.86MCNY
NormalMar 18, 2026
% Held by Insiders
0.5188CNY
NormalMar 18, 2026
% Held by Institutions
0.1481CNY
NormalMar 18, 2026
Total Cash (MRQ)
3.94BCNY
NormalMar 18, 2026
Total Cash per Share (MRQ)
9.38CNY
NormalMar 18, 2026
Total Debt (MRQ)
815.02MCNY
NormalMar 18, 2026
Total Debt to Equity (MRQ)
13.10CNY
AboveNormalMar 18, 2026
Current Ratio (MRQ)
3.64CNY
AboveNormalMar 18, 2026
Book Value per Share (MRQ)
14.48CNY
NormalMar 18, 2026
Total Assets
8.30B
NormalFY2024 · Dec 31, 2024
Total Current Assets
6.13B
NormalFY2024 · Dec 31, 2024
Total Liabilities
2.12B
NormalFY2024 · Dec 31, 2024
Total Non-current Assets
2.17B
NormalFY2024 · Dec 31, 2024
Total Non-current Liabilities
597.81M
NormalFY2024 · Dec 31, 2024
Total Current Liabilities
1.52B
NormalFY2024 · Dec 31, 2024
Cash
1.69B
NormalFY2024 · Dec 31, 2024
Cash Equivalents
117.64M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents
1.81B
NormalFY2024 · Dec 31, 2024
Other Short-term Investments
2.43B
NormalFY2024 · Dec 31, 2024
Accounts Receivable
691.21M
NormalFY2024 · Dec 31, 2024
Inventory
611.89M
NormalFY2024 · Dec 31, 2024
Accounts Payable
447.18M
NormalFY2024 · Dec 31, 2024
Short-term Debt
377.88M
NormalFY2024 · Dec 31, 2024
Other Current Liabilities
16.27M
NormalFY2024 · Dec 31, 2024
Long-term Debt
439.88M
NormalFY2024 · Dec 31, 2024
Common Stock (Book)
423.60M
NormalFY2024 · Dec 31, 2024
Retained Earnings
2.74B
NormalFY2024 · Dec 31, 2024
Total Shareholders' Equity
6.19B
NormalFY2024 · Dec 31, 2024
Treasury Stock
144.96M
ExtremeFY2024 · Dec 31, 2024
Market & Technical9
52-Week Low
37.46CNY
NormalMar 18, 2026
52-Week High
51.80CNY
NormalMar 18, 2026
52-Week Change
-8.30CNY
ExtremeMar 18, 2026
Beta
0.7120CNY
NormalMar 18, 2026
50-Day MA
44.24CNY
NormalMar 18, 2026
200-Day MA
44.39CNY
NormalMar 18, 2026
Avg 10-Day Volume
4.92MCNY
NormalMar 18, 2026
Avg 30-Day Volume
7.47MCNY
NormalMar 18, 2026
Diluted EPS (TTM)
0.8500CNY
NormalMar 18, 2026
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.